HILLSIDE HOSPITAL
1. Target Overview & Investment Thesis
HILLSIDE HOSPITAL is a 65-bed suburban community hospital in TRUMBULL, OH with $23.3M in net patient revenue and a 7.1% operating margin. The hospital serves a payer mix of 49.9% Medicare, 3.7% Medicaid, and 46.4% commercial.
Thesis: Turnaround. Our ML models identify $1.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.1% to 14.5% (+736bps).
| Net Revenue HCRIS | $23.3M |
| Current EBITDA COMPUTED | $1.7M |
| Operating Margin COMPUTED | 7.1% |
| Occupancy HCRIS | 52.3% |
| Revenue / Bed COMPUTED | $358K |
| Net-to-Gross HCRIS | 33.1% |
| Distress Probability ML | 49.9% |
2. Market Context & Competitive Position
OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 7.1% places it above the state median. Among 94 size-comparable peers (32-130 beds), the median margin is 1.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (32-130), prioritizing same-state peers. 94 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HILLSIDE HOSPITAL (Target) | OH | 65 | $23.3M | 7.1% |
| DUBLIN METHODIST HOSPITAL | OH | 110 | $333.9M | 28.4% |
| SOIN MEDICAL CENTER | OH | 120 | $256.3M | -1.3% |
| LIMA MEMORIAL HOSPITAL | OH | 110 | $253.5M | 6.4% |
| UH ST. JOHN MEDICAL CENTER | OH | 126 | $210.9M | 6.5% |
| KNOX COMMUNITY HOSPITAL | OH | 64 | $196.0M | -16.7% |
| UH GEAUGA MEDICAL CENTER | OH | 106 | $183.3M | 6.9% |
| CLEVELAND CLINIC AVON HOSPITAL | OH | 126 | $178.3M | 16.3% |
| CRYSTAL CLINIC ORTHOPAEDIC CEN | OH | 59 | $173.3M | -14.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $488K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $465K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $460K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $283K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $15K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $1.7M |
| + RCM Uplift | +$1.7M |
| Pro Forma EBITDA | $3.4M |
| Current Margin | 7.1% |
| Pro Forma Margin | 14.5% |
| WC Released (1x) | $892K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $2.5M | $28.0M | 11.03x | 61.6% |
| Base (11x exit) | 10.0x | 11.0x | $2.5M | $31.6M | 12.45x | 65.6% |
| Bull Case | 9.0x | 11.0x | $2.3M | $38.1M | 16.67x | 75.5% |
| Bull (12x exit) | 9.0x | 12.0x | $2.3M | $42.3M | 18.48x | 79.2% |
| Bear Case | 11.0x | 10.0x | $2.8M | $18.6M | 6.67x | 46.1% |
| Bear (11x exit) | 11.0x | 11.0x | $2.8M | $21.4M | 7.66x | 50.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 94 hospitals with 32-130 beds
- Same-state prioritization (n=95)
- Comp margins: P25=-14.5% / P50=1.4% / P75=9.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.